SCHEMBL4165696

SCHEMBL4165696

CC(O)Oc1c(-c2ccc(O)c(O)c2)oc2ccccc2c1=O

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.64
KDM4E B2RXH2 4/20 0.64
HSD17B10 Q99714 4/20 0.64
MEN1 O00255 3/20 0.64
KMT2A Q03164 3/20 0.64
TP53 P04637 3/20 0.64
CYP3A4 P08684 3/20 0.64
RECQL P46063 2/20 0.64
ST6GAL1 P15907 2/20 0.64
ALOX15 P16050 2/20 0.64
MAPK1 P28482 2/20 0.64
CYP2D6 P10635 1/20 0.64
CYP2C9 P11712 1/20 0.64
ALOX12 P18054 1/20 0.64
CDK2 P24941 1/20 0.64
CYP2C19 P33261 1/20 0.64
ABCG2 Q9UNQ0 2/20 0.54
TERT O14746 1/20 0.54
ALDH1A1 P00352 2/20 0.52
HPGD P15428 2/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7685641 0.88 MEN1 (0.64) MAPTKDM4EHSD17B10MEN1KMT2A
SCHEMBL3282447 0.85 KDM4E (0.71) MAPTKDM4EHSD17B10MEN1KMT2A
SCHEMBL22549001 0.83 POLH (0.74) MAPTKDM4EHSD17B10MEN1KMT2A
SCHEMBL16882942 0.81 KDM4E (0.68) MAPTKDM4EHSD17B10MEN1KMT2A
SCHEMBL4165699 0.79 POLH (0.71) MAPTKDM4EHSD17B10MEN1KMT2A
SCHEMBL2396323 0.79 HSD17B10 (0.66) MAPTKDM4EHSD17B10MEN1KMT2A
SCHEMBL4158838 0.79 TP53 (0.56) MAPTKDM4EHSD17B10MEN1KMT2A
SCHEMBL15676575 0.79 MEN1 (1.00) MAPTKDM4EHSD17B10MEN1KMT2A
SCHEMBL169366 0.79 MEN1 (1.00) MAPTKDM4EHSD17B10MEN1KMT2A
SCHEMBL30626973 0.79 MEN1 (1.00) MAPTKDM4EHSD17B10MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090130051-A1 Flavonoid Compounds and Uses Thereof HOWARD FLOREY INSTITUTE OF EXPERIMENTAL PHYSIOLOGY AND MEDICINE (AU) 2009-05-21 US claimed
US-20020147353-A1 Novel flavonoids VERENIGING CHRISTELIJK WETENSCHAPPELIJK ANDERWIJS (NL) 2002-10-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020147353-A1 Novel flavonoids H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, CBR1, ABCC8 MAPT 4588/4885KDM4E 3228/4885HSD17B10 892/4885
US-20090130051-A1 Flavonoid Compounds and Uses Thereof CAT, NQO1, GPX4 MAPT 3887/4885KDM4E 4144/4885HSD17B10 1555/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.